Induced pluripotent stem cell technology: a decade of progress

Y Shi, H Inoue, JC Wu, S Yamanaka - Nature reviews Drug discovery, 2017 - nature.com
Since the advent of induced pluripotent stem cell (iPSC) technology a decade ago,
enormous progress has been made in stem cell biology and regenerative medicine. Human …

[HTML][HTML] Non-invasive brain stimulation and neuroenhancement

A Antal, B Luber, AK Brem, M Bikson… - Clinical neurophysiology …, 2022 - Elsevier
Attempts to enhance human memory and learning ability have a long tradition in science.
This topic has recently gained substantial attention because of the increasing percentage of …

[HTML][HTML] A transcription factor atlas of directed differentiation

J Joung, S Ma, T Tay, KR Geiger-Schuller… - Cell, 2023 - cell.com
Transcription factors (TFs) regulate gene programs, thereby controlling diverse cellular
processes and cell states. To comprehensively understand TFs and the programs they …

Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping

P Gee, MSY Lung, Y Okuzaki, N Sasakawa… - Nature …, 2020 - nature.com
Prolonged expression of the CRISPR-Cas9 nuclease and gRNA from viral vectors may
cause off-target mutagenesis and immunogenicity. Thus, a transient delivery system is …

Engineering human pluripotent stem cells into a functional skeletal muscle tissue

L Rao, Y Qian, A Khodabukus, T Ribar… - Nature …, 2018 - nature.com
The generation of functional skeletal muscle tissues from human pluripotent stem cells
(hPSCs) has not been reported. Here, we derive induced myogenic progenitor cells (iMPCs) …

Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9

HL Li, N Fujimoto, N Sasakawa, S Shirai, T Ohkame… - Stem cell reports, 2015 - cell.com
Duchenne muscular dystrophy (DMD) is a severe muscle-degenerative disease caused by a
mutation in the dystrophin gene. Genetic correction of patient-derived induced pluripotent …

CRISPR-Cas3 induces broad and unidirectional genome editing in human cells

H Morisaka, K Yoshimi, Y Okuzaki, P Gee… - Nature …, 2019 - nature.com
Although single-component Class 2 CRISPR systems, such as type II Cas9 or type V
Cas12a (Cpf1), are widely used for genome editing in eukaryotic cells, the application of …

Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro

J Chal, Z Al Tanoury, M Hestin, B Gobert, S Aivio… - Nature protocols, 2016 - nature.com
Progress toward finding a cure for muscle diseases has been slow because of the absence
of relevant cellular models and the lack of a reliable source of muscle progenitors for …

iPS cells: a game changer for future medicine

H Inoue, N Nagata, H Kurokawa, S Yamanaka - The EMBO journal, 2014 - embopress.org
The induced pluripotent stem cell (i PSC) technology is instrumental in advancing the fields
of disease modeling and cell transplantation. We herein discuss the various issues …

Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy

J Chal, M Oginuma, Z Al Tanoury, B Gobert… - Nature …, 2015 - nature.com
During embryonic development, skeletal muscles arise from somites, which derive from the
presomitic mesoderm (PSM). Using PSM development as a guide, we establish conditions …